Regenxbio Inc
RGNX
Market Cap$422.76M
Close$
$25.02
204.7% upside
Current Fair Value
204.7% upsideUndervalued by 204.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $422.76 Million |
|---|---|
| Enterprise Value | $405.14 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.59 |
| Beta | 1.09 |
| Outstanding Shares | 51,362,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.73 |
|---|---|
| PEG | 2.49 |
| Price to Sales | 2.74 |
| Price to Book Ratio | 1.64 |
| Enterprise Value to Revenue | 2.59 |
| Enterprise Value to EBIT | -2.74 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Regenxbio Inc
CEO: Kenneth Mills